MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY for MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Incentives for health information technology, Affordable Care Act implementation and other healthcare policy issues. Proposed regulation of medical software. Food and Drug Administration Safety and Innovation ActH.R. 2746, the Cancer Drug Coverage Parity Act. S. 752, the Lung Cancer Mortality Reduction Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
| MATT BROW | — |
| KEAGAN R LENIHAN | — |
| GEOFF WERTH | — |
Medicare/Medicaid MMM
Physician and pharmacy reimbursement issues. Implementation of the Affordable Care Act. H.R. 800, a bill to remove the prompt pay discount between the manufacturer and the distributor from the providers Medicare Part B drug reimbursement.H.R. 905/S.733, to amend Part B of title XVIII of the Social Security Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
| MATT BROW | — |
| KEAGAN R LENIHAN | — |
| GEOFF WERTH | — |
Veterans VET
Existing Department of Veterans' Affairs Pharmaceutical Prime Vendor Contract.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
Taxation/Internal Revenue Code TAX
Implementation of the new medical device tax. Proposals to repeal LIFO.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
Pharmacy PHA
Pharmacy issues Prescription drug supply chain issues, including security of the supply chain, drug shortages, prescription drug abuse and diversion.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.